Skip to main content


Log in

Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript


Osteosarcoma (OS), a lethal malignancy, has witnessed an escalating incidence rate. Contemporary therapeutic strategies for this cancer have proven to be inadequate, primarily due to their extensive side effects and the lack of specificity in targeting the molecular pathways implicated in this disease. Consequently, this project is aimed to manufacture and characterize Poly (Lactic-co-glycolic acid) embodying curcumin, a phytocompound devoid of adverse effects which not only exerts an anti-neoplastic influence but also significantly modulates the genetic pathways associated with this malignancy. In this investigation, multiple formulations of PLGA-Cur were synthesized, and the choice of optimal formula was made considering the efficiency of nanoparticle encapsulation and the drug dispersion rate from synthesized PLGA. The selected formulation’s physical and chemical attributes, such as its dimension, polydispersity index of the formulation, surface electrical charge, physical-spatial structure, and stability, were examined using methods, including Dynamic light scattering (DLS), Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM), and spectrophotometry. Subsequently, the absence of interaction between the drug and the system was assessed using Fourier Transform Infrared Spectroscopy (FT-IR), and cellular uptake was evaluated using fluorescence microscopy. The smart system’s responsiveness to environmental stimuli was determined using the dialysis bag method and its anti-tumor properties were investigated on the SAOS-2 cell line. Finally, to evaluate the system’s genetic impact on bone cancer, the molecular quantification of the P53 tumor suppressor gene and the oncogene MCL-2 was analyzed using real-time PCR and their protein expression levels were also examined. The PLGAs synthesized in this study exhibited an encapsulation rate of 91.5 ± 1.16% and a maximum release rate of 71 ± 1%, which were responsive to various stimuli. The size of the PLGAs was 12.5 ± 321.2 nm, with an electric charge of -38.9 ± 2.6 mV and a PDI of 0.107, indicating suitable morphology and stability. Furthermore, both the system and the drug retained their natural properties after inoculation. The system was readily absorbed by cancer cells and effectively exerted its anti-cancer properties. Notably, the system had a significant impact on the mentioned genes’ expression. The produced nanosystem, possessing optimal physicochemical properties, has the potential to enhance the anti-cancer efficacy of curcumin. This is achieved by altering molecular and genetic pathways within cancer cells, thereby positioning it as a viable adjunctive treatment modality and also synthesizing of this herbal base drug system consider as a completely novel method for cancer therapy that can efficiently modulate genetical pathways involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others


  1. Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, et al. Osteosarcoma: cells-of-origin, cancer stem cells, and targeted therapies. Stem Cells Int. 2016;2016.

  2. Hausser H-J, Brenner RE. Phenotypic instability of Saos-2 cells in long-term culture. Biochem Biophys Res Commun. 2005;333(1):216–22.

    Article  CAS  PubMed  Google Scholar 

  3. Taebpour M, Akhlaghi M, Shahriyari S, Hajihosseini S, Haghiralsadat BF, Oroojalian F, Tofighi D. Synthesis, physicochemical characterization and pharmaceutical function of niosomal nanoparticles-encapsulated bioactive compound for osteosarcoma treatment. Nanomed J. 2022;9(3):205–15.

    CAS  Google Scholar 

  4. Durfee RA, Mohammed M, Luu HH. Review of osteosarcoma and current management. Rheumatol Ther. 2016;3:221–43.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mittal P, Singh S, Sinha R, Shrivastava A, Singh A, Singh IK. Myeloid cell leukemia 1 (MCL-1): structural characteristics and application in cancer therapy. Int J Biol Macromol. 2021;187:999–1018.

    Article  CAS  PubMed  Google Scholar 

  6. Cao L, Wang J, Wang Q. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma. Biomed Pharmacother. 2016;84:828–35.

    Article  CAS  PubMed  Google Scholar 

  7. Kim H, Yoo S, Zhou R, Xu A, Bernitz JM, Yuan Y, et al. Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism. Proc Natl Acad Sci. 2018;115(47):E11128–37.

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  8. Taebpour M, Majdizadeh M, Akhlaghi M. Fabrication Of Liposomal Nanoparticles Containing Hydroalcoholic Extract Of Silybum Marianum And Evaluation Of Its Toxicity On Human Osteosarcoma Cancer Cell Line (Saos-2) And Evaluation Effect Of Free Hydroalcoholic Extract Of Silybum Marianum And Empty Liposomes On Healthy Human Fibroblast Cell (Hff). 2021.

  9. Mohseni M, Dehghani Ashkezari M, Akhlaghi M, Ansari K, Haghirosadat BF. A new therapeutic approach for the treatment of breast cancer using synthesis of liposomes containing silybinin and their characterization. New Cell Mol Biotechnol J. 2021;11(44):57–70.

    Google Scholar 

  10. Kerry RG, Singh KR, Mahari S, Jena AB, Panigrahi B, Pradhan KC, et al. Bioactive potential of morin loaded mesoporous silica nanoparticles: a nobel and efficient antioxidant, antidiabetic and biocompatible abilities in in-silico, in-vitro, and in-vivo models. OpenNano. 2023;10: 100126.

    Article  Google Scholar 

  11. Ghafari M, Haghiralsadat F, Khanamani Falahati-pour S, Zavar RJ. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. J Cell Biochem. 2020;121(7):3584–92.

    Article  CAS  PubMed  Google Scholar 

  12. Taebpour M, Arasteh F, Akhlaghi M, Haghirosadat BF, Oroojalian F, Tofighi D. Fabrication and characterization of PLGA polymeric nanoparticles containing Berberine and its cytotoxicity on breast cancer cell (MCF-7). Nanomed Res J. 2021;6(4):396–408.

    CAS  Google Scholar 

  13. Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, Zandieh-Doulabi B. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. Int J Polym Mater Polym Biomater. 2018;67(6):383–400.

    Article  CAS  Google Scholar 

  14. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199–225.

    Article  CAS  PubMed  Google Scholar 

  15. Barati N, Momtazi-Borojeni AA, Majeed M, Sahebkar A. Potential therapeutic effects of curcumin in gastric cancer. J Cell Physiol. 2019;234(3):2317–28.

    Article  CAS  PubMed  Google Scholar 

  16. Alpers DH. The potential use of curcumin in management of chronic disease: too good to be true? Curr Opin Gastroenterol. 2008;24(2):173–5.

    Article  PubMed  Google Scholar 

  17. Akhlaghi M, Eftekharivash L, Parnian F, Taebpour M, Rostamian T, Zarezadeh Mehrizi M, et al. Synthesis and study of cellular and physicochemical properties of nanoliposomes containing aqueous extract of Hedera Helix. New Cell Mol Biotechnol J. 2021;12(45):97–112.

    Google Scholar 

  18. Ghashghaei M, Akhlaghi M. Investigation of nanoniosomal formulation containing doxorubicin effect on ovarian cancer cell line (OVCAR-3 cell line). New Cell Mol Biotechnol J. 2021;11(43):46–62.

    Google Scholar 

  19. Taebpour M, Akhlaghi M, Shahriary S, Hajihosseini S, Haghiralsadat F, Oroojalian F, Tofighi D. Synthesis, physicochemical characterization and pharmaceutical function of niosomal nanoparticles-encapsulated bioactive compound for osteosarcoma treatment. Nanomed J. 2022;9(3).

  20. Akhlaghi M, Taebpour M, Lotfabadi NN, Naghib SM, Jalili N, Farahmand L, et al. Synthesis and characterization of smart stimuli-responsive herbal drug-encapsulated nanoniosome particles for efficient treatment of breast cancer. Nanotechnol Rev. 2022;11(1):1364–85.

    Article  CAS  Google Scholar 

  21. Yasin NF, Abdul Rashid ML, Ajit SV. Survival analysis of osteosarcoma patients: a 15-year experience. J Orthop Surg. 2020;28(1):2309499019896662.

    Article  Google Scholar 

  22. Xu N, Wang X, Wang L, Song Y, Zheng X, Hu H. Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data. Front Genet. 2022;13:1013737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ebrahimpour M, Akhlaghi M, Hemati M, Ghazanfary S, Shahriary S, Ghalekohneh SJ, et al. In vitro evaluation and comparison of anticancer, antimicrobial, and antifungal properties of thyme niosomes containing essential oil. Nanomed J. 2022;9(4).

  24. Peng S-F, Lee C-Y, Hour M-J, Tsai S-C, Kuo D-H, Chen F-A, et al. Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway. Int J Oncol. 2014;44(1):238–46.

    Article  CAS  PubMed  Google Scholar 

  25. Azizi M, Farahmandghavi F, Joghataei M, Zandi M, Imani M, Bakhtiary M, et al. Fabrication of protein-loaded PLGA nanoparticles: effect of selected formulation variables on particle size and release profile. J Polym Res. 2013;20:1–14.

    Article  CAS  Google Scholar 

  26. Ungaro F, d’Angelo I, Coletta C, di Villa Bianca RDE, Sorrentino R, Perfetto B, et al. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J Contr Rel. 2012;157(1):149–59.

    Article  CAS  Google Scholar 

  27. Rivera P, Martinez-Oharriz M, Rubio M, Irache J, Espuelas S. Fluconazole encapsulation in PLGA microspheres by spray-drying. J Microencapsul. 2004;21(2):203–11.

    Article  CAS  PubMed  Google Scholar 

  28. Adebileje T, Valizadeh A, Amani A. Effect of formulation parameters on the size of PLGA nanoparticles encapsulating bovine serum albumin: a response surface methodology. J Contemp Med Sci. 2017;3(12).

  29. Lagreca E, Onesto V, Di Natale C, La Manna S, Netti PA, Vecchione R. Recent advances in the formulation of PLGA microparticles for controlled drug delivery. Prog Biomater. 2020;9:153–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Sadeghi M, Kashanian S, Naghib SM, Askari E, Haghiralsadat F, Tofighi D. A highly sensitive nanobiosensor based on aptamer-conjugated graphene-decorated rhodium nanoparticles for detection of HER2-positive circulating tumor cells. Nanotechnol Rev. 2022;11(1):793–810.

    Article  CAS  Google Scholar 

  31. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Trop J Pharm Res. 2013;12(2):265–73.

    Google Scholar 

  32. Zhang Y, Yang M, Portney NG, Cui D, Budak G, Ozbay E, et al. Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevice. 2008;10:321–8.

    Article  CAS  Google Scholar 

  33. Tila D, Yazdani-Arazi SN, Ghanbarzadeh S, Arami S, Pourmoazzen Z. pH-sensitive, polymer modified, plasma stable niosomes: promising carriers for anti-cancer drugs. EXCLI J. 2015;14:21.

    PubMed  PubMed Central  Google Scholar 

  34. Ahmed R, Tariq M, Ahmad IS, Fouly H, Hasan A, Kushad M. Poly (lactic-co-glycolic acid) nanoparticles loaded with Callistemon citrinus phenolics exhibited anticancer properties against three breast cancer cell lines. J Food Qual. 2019;2019.

  35. Karimi N, Ghanbarzadeh B, Hamishehkar H, KEYVANI F, Pezeshki A, Gholian MM. Phytosome and liposome: the beneficial encapsulation systems in drug delivery and food application. 2015.

  36. Nakayama M, Oshima M. Mutant p53 in colon cancer. J Mol Cell Biol. 2019;11(4):267–76.

    Article  CAS  PubMed  Google Scholar 

  37. Seo BR, Min K-J, Cho IJ, Kim SC, Kwon TK. Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability. PloS One. 2014;9(4):e95588.

    Article  PubMed  PubMed Central  ADS  Google Scholar 

  38. Seo SU, Woo SM, Lee H-S, Kim SH, Min K-J, Kwon TK. mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy. Oncogene. 2018;37(38):5205–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references


No funding was received to assist with the preparation of this manuscript.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Bibi Fatemeh Haghirosadat, Abbas Rahdar or Sadanand Pandey.

Ethics declarations

Competing interest

The authors declare that they have no competing financial interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akbari, P., Taebpour, M., Akhlaghi, M. et al. Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment. Med Oncol 41, 68 (2024).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: